Literature DB >> 24039226

Nebulizing poractant alfa versus conventional instillation: Ultrastructural appearance and preservation of surface activity.

Stefan Minocchieri1, Stephan Knoch, W Michael Schoel, Matthias Ochs, Mathias Nelle.   

Abstract

BACKGROUND: Nebulized surfactant therapy has been proposed as an alternative method of surfactant administration. The use of a perforated vibrating membrane nebulizer provides a variety of advantages over conventional nebulizers. We investigated the molecular structure and integrity of poractant alfa pre- and post-nebulization.
METHOD: Curosurf® was nebulized using an Investigational eFlow® Nebulizer System. Non-nebulized surfactant ("NN"), recollected surfactant droplets from nebulization through an endotracheal tube ("NT") and nebulization of surfactant directly onto a surface ("ND") were investigated by transmission electron microscopy. Biophysical characteristics were assessed by the Langmuir-Wilhelmy balance and the Captive Bubble Surfactometer.
RESULTS: Volume densities of lamellar body-like forms (LBL) and multi-lamellar forms (ML) were high for "NN" and "NT" samples (38.8% vs. 47.7% for LBL and 58.2% vs. 47.8% for ML). In the "ND" sample, we found virtually no LBL's, ML's (72.6%) as well as uni-lamellar forms (16.4%) and a new structure, the "garland-like" forms (9.4%). Surface tension for "NN" and "NT" was 23.33 ± 0.29 and 25.77 ± 1.12 mN/m, respectively. Dynamic compression-expansion cycling minimum surface tensions were between 0.91 and 1.77 mN/m.
CONCLUSION: The similarity of surfactant characteristics of nebulized surfactant via a tube and the non-nebulized surfactant suggests that vibrating membrane nebulizers are suitable for surfactant nebulization. Alterations in surfactant morphology and characteristics after nebulization were transient. A new structural subtype of surfactant was identified.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  aerosol drug therapy; nebulizer; neonatal respiratory distress syndrome; pulmonary surfactant; surface tension

Mesh:

Substances:

Year:  2013        PMID: 24039226     DOI: 10.1002/ppul.22838

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.

Authors:  Matthias C Hütten; Elke Kuypers; Daan R Ophelders; Maria Nikiforou; Reint K Jellema; Hendrik J Niemarkt; Carola Fuchs; Markus Tservistas; Roberta Razetti; Federico Bianco; Boris W Kramer
Journal:  Pediatr Res       Date:  2015-08-31       Impact factor: 3.756

2.  Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.

Authors:  Amy Z Stetten; Steven V Iasella; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  Curr Opin Colloid Interface Sci       Date:  2018-01-13       Impact factor: 6.448

3.  Enabling Marangoni flow at air-liquid interfaces through deposition of aerosolized lipid dispersions.

Authors:  Amy Z Stetten; Grace Moraca; Timothy E Corcoran; Stephanie Tristram-Nagle; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  J Colloid Interface Sci       Date:  2016-08-31       Impact factor: 8.128

4.  Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis.

Authors:  Christine S M Lau; Ronald S Chamberlain; Shyan Sun
Journal:  Glob Pediatr Health       Date:  2017-03-24

5.  Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Authors:  Carmen Rey-Santano; Victoria E Mielgo; Miguel Angel Gomez-Solaetxe; Federico Bianco; Fabrizio Salomone; Begoña Loureiro
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

6.  Does surfactant nebulization prevent early intubation in preterm infants? A protocol for a systematic review and meta-analysis.

Authors:  Vincent D Gaertner; Dirk Bassler; Christoph M Rüegger
Journal:  Syst Rev       Date:  2021-01-06

7.  Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Authors:  Carmen Rey-Santano; Victoria Mielgo; Miguel Angel Gomez-Solaetxe; Francesca Ricci; Federico Bianco; Fabrizio Salomone; Begoña Loureiro
Journal:  Pediatr Crit Care Med       Date:  2020-07       Impact factor: 3.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.